IRIDEX Board Alleges Director-Led Stealth Proxy Campaign and Securities Law Violations by Largest Stockholder

summarizeSummary

IRIDEX's board has revealed a stealth proxy campaign by director William Moore and largest stockholder Novel Inspiration aimed at unseating two independent directors, alleging fiduciary breaches and securities law violations. Novel's group holds approximately 39% of common shares, and the board is investigating potential insider trading.

check_boxKey Events · Corporate Governance and Compliance · IRIX

• Stealth Proxy Campaign Exposed

  A board majority alleges that director William Moore and Novel Inspiration orchestrated a covert campaign to withhold votes from independent directors Beverly Huss and Scott Shuda at the 2026 Annual Meeting, violating fiduciary duties and federal proxy solicitation rules.

• Undisclosed Group and 13D Violations

  Novel and a 'Group of 17' stockholders cast identical proxy votes, and Novel's July 13 Schedule 13D/A belatedly disclosed open market purchases dating back to March 2025, bringing its group stake to approximately 39% of common shares (29.9% fully diluted).

• Potential Insider Trading Investigated

  The board is investigating whether Novel or its affiliates traded during closed windows or participated in heavy selling on March 27, 2026, when the stock dropped 30% just before Novel proposed a dilutive conversion repricing.

• Conversion Repricing Dispute

  Novel seeks to reprice the Series B Preferred conversion to the current market, which would issue over 2 million incremental shares (approximately 10% dilution); the board majority opposes the move, citing harm to other stockholders.

auto_awesomeAnalysis · IRIX · Industrial Applications And Services

A board majority has accused director William Moore and Novel Inspiration of running a covert campaign to remove two independent directors, a move that allegedly breaches fiduciary duties and federal proxy rules. Novel's group now controls roughly 39% of common shares, and the board is probing potential insider trading tied to a sharp stock decline in March 2026. The unfolding governance crisis threatens board stability, exposes the company and insiders to SEC enforcement, and further strains an already difficult relationship with its key investor. Adding to the pressure, the filing reveals Novel's push for a dilutive conversion repricing that the board opposes, creating a capital-structure overhang.